Chips Stacked Against Intel?

Recs

0

By all appearances, Intel (Nasdaq: INTC) turned in a solid quarter.

Sales, net income, and earnings per share were up 14.7%, 16%, and 22.2% respectively. Considering the company's sales and net income figures are in the billions, that's solid growth. On the balance sheet, the company also managed to work down its inventory from a quite high $3.2 billion last year to $2.7 billion this year.

This inventory improvement is the most interesting aspect, because it seems to have come at the expense of margins. This adds a bit to the story that AMD's (NYSE: AMD) headway into Intel's business is a real cause for concern. AMD's microprocessor business is booming, and most observers believe it has a current and persistent technological advantage in the PC processor arena. As you look at Intel's increased sales and decreased inventory, that 3% drop in gross margins versus the same period last year is disconcerting.

This morning, I saw a number of comments attributing Intel's 5% stock slide today to its overly rich price and its failure to surpass estimates. That may be. Thankfully, I'm not in the business of trying to explain a one-day move.

But if I had to pick the most significant aspect of today's Intel news, I'd choose the competitive threats Intel faces, and its decline in margins, over its earnings. Yes, microprocessor sales were a record for the quarter, but that was helped by Microsoft (Nasdaq: MSFT) Xbox sales and a surprisingly strong PC market.

I'm not crazy enough to predict that Intel will lose its dominance any time soon. The company can use its very strong free cash flow to regain control of the market and its margins, and it should also have a decent amount of Apple (Nasdaq: AAPL) sales arriving in the next year. Still, I'd pay attention to those margins. Intel's been wrestling with its inventory for a while now, and while the company aims for gross margins in the 59% range, recent quarters show it's been a tough target of late.

For related Foolishness check out:

Nathan Parmelee has no financial interest in any of the companies mentioned. The Motley Fool has an ironclad disclosure policy.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 494182, ~/Articles/ArticleHandler.aspx, 12/2/2009 9:21:10 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
Is Everybody Losing It in Finance's Nervous Breakdown?

Related Tickers

12/1/2009 4:00 PM
AMD $7.20 Up +0.19 +2.71%
Advanced Micro Dev… CAPS Rating: **
AAPL $196.97 Down -2.94 -1.47%
Apple, Inc. CAPS Rating: ***
INTC $19.66 Up +0.46 +2.40%
Intel Corp CAPS Rating: ****
MSFT $30.01 Up +0.60 +2.04%
Microsoft Corp CAPS Rating: ***

Community: Investing Wiki

Term Of The Hour

Series 7: Series 7 is a test given by the non-governmental Financial Industry Regulatory Authority (FINRA); a person passing the test is deemed ready and able to solicit, buy, and sell securities products. The Series 7 is usually taken by beginning stockbrokers-to-be who are sponsored by financial firms.

Want to learn more or edit this definition?
Click here to read more!